Small Molecule API Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Small Molecule API Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic compound, which may help to control biological process. Most of the small molecules can be administered orally and are most likely to be absorbed by the body. Owing to its small size it has properties of rapid diffusibility to reach the intracellular site of action.
Market Dynamics
Growing expansion of small molecule API manufacturers in the Asia Pacific region is a major factor driving the small molecule API market growth. For instance, BASF is planning to build a new specialty amines plant at its existing site in Nanjing Chemical Industry Park, China. This new multi-product plant will be able to manufacture 21,000 metric tons of amines year, and it extends BASF’s amines portfolio at the specialty amines complex in Nanjing. The plant is scheduled to stream by 2019. Moreover the small molecule API manufacturers have planned to add global sales and business development staff, followed by quality, regulatory, and project management teams, which have positively influenced growth of the market.
However, stringent regulatory policies for API manufacturing may hinder the market growth. Stringent global regulatory policies on quality assessments of small molecule API manufacturing, facility certification, and increased supply chain security issues across emerging countries have a large impact on the cost of final small molecule API products. The new entrants willing to enter into small molecule API manufacturing are facing financial challenges, owing to aforementioned factors.
Key features of the study:
This report provides in-depth analysis of the small molecule API market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, impact analysis, PEST analysis, collaborations, mergers and acquisitions, regulatory scenarios, technological advancements, steps to manufacture small molecule API, major suppliers of small molecule APIs, market trends
It profiles key players in the global small molecule API market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Lonza, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Aesica Pharmaceuticals Ltd., Albemarle Corporation, Cambrex Corporation, BASF SE, Gland Pharma Limited, Gilead Sciences, Inc., AstraZeneca Plc, Baxter International Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, Piramal Pharma Solutions, Recipharm AB, Evonik Industries AG, Glenmark Pharmaceuticals Limited, Siegfried AG, AbbVie Contract Manufacturing, Aurinia Pharmaceuticals Inc., Bayer AG, Patheon, CordenPharma International
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global small molecule API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the small molecule API market
Detailed Segmentation:
Global Small Molecule API Market, By API Type:
Artificial
Natural
Global Small Molecule API Market, By Category:
Analgesic
Anesthetics
Anticonvulsants
Antimetabolites
Antibacterial
Alkylating Agents
Others
Global Small Molecule API Market, By Geography:
North America
By API Type:
Artificial
Natural
By Category:
Analgesic
Anesthetics
Anticonvulsants
Antimetabolites
Antibacterial
Alkylating Agents
Others
By Country:
U.S.
Canada
Latin America
By API Type:
Artificial
Natural
By Category:
Analgesic
Anesthetics
Anticonvulsants
Antimetabolites
Antibacterial
Alkylating Agents
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By API Type:
Artificial
Natural
By Category:
Analgesic
Anesthetics
Anticonvulsants
Antimetabolites
Antibacterial
Alkylating Agents
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By API Type:
Artificial
Natural
By Category:
Analgesic
Anesthetics
Anticonvulsants
Antimetabolites
Antibacterial
Alkylating Agents
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By API Type:
Artificial
Natural
By Category:
Analgesic
Anesthetics
Anticonvulsants
Antimetabolites
Antibacterial
Alkylating Agents
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By API Type:
Artificial
Natural
By Category:
Analgesic
Anesthetics
Anticonvulsants
Antimetabolites
Antibacterial
Alkylating Agents
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Lonza *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Pfizer, Inc.
Aesica Pharmaceuticals Ltd.
Albemarle Corporation
Cambrex Corporation
BASF SE
Gland Pharma Limited
Gilead Sciences, Inc.
AstraZeneca Plc
Baxter International Inc.
Boehringer Ingelheim International GmbH
Celgene Corporation
Piramal Pharma Solutions
Recipharm AB
Evonik Industries AG
Glenmark Pharmaceuticals Limited
Siegfried AG
AbbVie Contract Manufacturing
Aurinia Pharmaceuticals Inc.
Bayer AG
Patheon
CordenPharma International
“*” marked represents similar segmentation in other categories in the respective section.